GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders

Journal of Neuroimmunology

Volumn 281, Issue , 2015, Pages 73-77

  Fouka, P ^a,b   Alexopoulos, H ^a   Akrivou, S ^a   Trohatou, O ^b   Politis, P K ^b   Dalakas, M C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Academy of Athens Biomedical Research Foundation   (Greece)

Author keywords

Anti GAD antibodies; Autoimmunity; Epilepsy; GABA; Stiff person syndrome; Synapse

Indexed keywords

ANTICONVULSIVE AGENT; EPITOPE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; STEROID; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BRAIN NERVE CELL; CEREBELLAR ATAXIA; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; ENCEPHALITIS; EPILEPSY; EPITOPE MAPPING; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; STIFF MAN SYNDROME; ANIMAL; BLOOD; CELL CULTURE; HEK293 CELL LINE; METABOLISM; NERVE CELL; NERVOUS SYSTEM DISEASES; PROCEDURES;

ANIMALS; AUTOANTIBODIES; CELLS, CULTURED; EPITOPE MAPPING; GLUTAMATE DECARBOXYLASE; HEK293 CELLS; HUMANS; MICE; NERVOUS SYSTEM DISEASES; NEURONS;

EID: 84928142925     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.03.009     Document Type: Article

References (35)

1. Alexopoulos H., Dalakas M.C. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert. Rev. Clin. Immunol. 2013, 9:1043-1053.
2. Alexopoulos H., Akrivou S., Dalakas M.C. Glycine receptor antibodies in stiff-person syndrome and other GAD-positive CNS disorders. Neurology 2013, 81:1962-1964.
3. Burbelo P.D., Groot S., Dalakas M.C., Iadarola M.J. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochem. Biophys. Res. Commun. 2008, 366:1-7.
4. Burbelo P.D., Ching K.H., Klimavicz C.M., Iadarola M.J. Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J. Vis. Exp. 2009, 32:1549.
5. Butler M.H., Solimena M., Dirkx R., Hayday A., De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J. Exp. Med. 1993, 178:2097-2106.
6. Chang T., Alexopoulos H., McMenamin M., Carvajal-Gonzalez A., Alexander S.K., Deacon R., Erdelyi F., Gabor S., Lang B., Blaes F., Brown P., Vincent A. Neuronal surface and glutamic acid decarboxylase autoantibodies in nonparaneoplastic stiff person syndrome. JAMA Neurol. 2013, 70:1140-1149.
7. Chang T., Alexopoulos H., Pettingill P., McMenamin M., Deacon R., Erdelyi F., Szabo G., Buckley C.J., Vincent A. Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss. PLoS One 2013, 8:e72921.
8. Dalakas M.C. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr. Treat. Options Neurol. 2009, 11:102-110.
9. Dalakas M.C., Fujii M., Li M., McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 2000, 55:1531-1535.
10. Dalakas M.C., Li M., Fujii M., Jacobowitz D.M. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 2001, 57:780-784.
11. De Camilli P., Thomas A., Cofiell R., Folli F., Lichte B., Piccolo G., Meinck H.M., Austoni M., Fassetta G., Bottazzo G., et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J. Exp. Med. 1993, 178:2219-2223.
12. Dinkel K., Meinck H.M., Jury K.M., Karges W., Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann. Neurol. 1998, 44:194-201.
13. Falip M., Carreno M., Miro J., Saiz A., Villanueva V., Quilez A., Molins A., Barcelo I., Sierra A., Graus F. Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. Eur. J. Neurol. 2012, 19:827-833.
14. Fenalti G., Buckle A.M. Structural biology of the GAD autoantigen. Autoimmun. Rev. 2010, 9:148-152.
15. Folli F., Solimena M., Cofiell R., Austoni M., Tallini G., Fassetta G., Bates D., Cartlidge N., Bottazzo G.F., Piccolo G., et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N. Engl. J. Med. 1993, 328:546-551.
16. Giometto B., Miotto D., Faresin F., Argentiero V., Scaravilli T., Tavolato B. Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia. J. Neurol. Sci. 1996, 143:57-59.
17. Honnorat J., Saiz A., Giometto B., Vincent A., Brieva L., de Andres C., Maestre J., Fabien N., Vighetto A., Casamitjana R., Thivolet C., Tavolato B., Antoine J., Trouillas P., Graus F. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch. Neurol. 2001, 58:225-230.
18. Hughes E.G., Peng X., Gleichman A.J., Lai M., Zhou L., Tsou R., Parsons T.D., Lynch D.R., Dalmau J., Balice-Gordon R.J. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J. Neurosci. 2010, 30:5866-5875.
19. Kampylafka E.I., Routsias J.G., Alexopoulos H., Dalakas M.C., Moutsopoulos H.M., Tzioufas A.G. Fine specificity of antibodies against AQP4: epitope mapping reveals intracellular epitopes. J. Autoimmun. 2011, 36:221-227.
20. Kim J., Namchuk M., Bugawan T., Fu Q., Jaffe M., Shi Y., Aanstoot H.J., Turck C.W., Erlich H., Lennon V., Baekkeskov S. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 1994, 180:595-606.
21. Levy L.M., Dalakas M.C., Floeter M.K. The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann. Intern. Med. 1999, 131:522-530.
22. Malter M.P., Helmstaedter C., Urbach H., Vincent A., Bien C.G. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann. Neurol. 2010, 67:470-478.
23. McKeon A., Martinez-Hernandez E., Lancaster E., Matsumoto J.Y., Harvey R.J., McEvoy K.M., Pittock S.J., Lennon V.A., Dalmau J. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013, 70:44-50.
24. Moss S.J., Smart T.G. Constructing inhibitory synapses. Nat. Rev. Neurosci. 2001, 2:240-250.
25. Ohkawa T., Satake S., Yokoi N., Miyazaki Y., Ohshita T., Sobue G., Takashima H., Watanabe O., Fukata Y., Fukata M. Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis. J. Neurosci. 2014, 34:8151-8163.
26. Peltola J., Kulmala P., Isojarvi J., Saiz A., Latvala K., Palmio J., Savola K., Knip M., Keranen T., Graus F. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000, 55:46-50.
27. Petit-Pedrol M., Armangue T., Peng X., Bataller L., Cellucci T., Davis R., McCracken L., Martinez-Hernandez E., Mason W.P., Kruer M.C., Ritacco D.G., Grisold W., Meaney B.F., Alcala C., Sillevis-Smitt P., Titulaer M.J., Balice-Gordon R., Graus F., Dalmau J. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014, 13:276-286.
28. Pettingill P., Kramer H.B., Coebergh J.A., Pettingill R., Maxwell S., Nibber A., Malaspina A., Jacob A., Irani S.R., Buckley C., Beeson D., Lang B., Waters P., Vincent A. Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization. Neurology 2015, 10.1212/WNL [Epub ahead of print] PMID:25636913.
29. Raju R., Foote J., Banga J.P., Hall T.R., Padoa C.J., Dalakas M.C., Ortqvist E., Hampe C.S. Analysis of GAD65 autoantibodies in stiff-person syndrome patients. J. Immunol. 2005, 175:7755-7762.
30. Raju R., Rakocevic G., Chen Z., Hoehn G., Semino-Mora C., Shi W., Olsen R., Dalakas M.C. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain 2006, 129:3270-3276.
31. Solimena M., Folli F., Denis-Donini S., Comi G.C., Pozza G., De Camilli P., Vicari A.M. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N. Engl. J. Med. 1988, 318:1012-1020.
32. Solimena M., Butler M.H., De Camilli P. GAD, diabetes, and stiff-man syndrome: some progress and more questions. J. Endocrinol. Invest. 1994, 17:509-520.
33. Vaknin-Dembinsky A., Karussis D., Avichzer J., Abramsky O. NMO spectrum of disorders: a paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases. J. Autoimmun. 2014, 54:93-99.
34. Vincent A. Stiff, twitchy or wobbly: are GAD antibodies pathogenic?. Brain 2008, 131:2536-2537.
35. Vincent A., Bien C.G., Irani S.R., Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol. 2011, 10:759-772.